Bravida (BRAV) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
23 Oct, 2026Executive summary
Q3 net sales rose 9% YoY to SEK 7,027m, organic growth was 9%, and order intake increased 72% to SEK 10,317m; order backlog reached a record SEK 24,216m, up 48%.
EBITA grew 34% to SEK 460m and margin expanded to 6.5%; profit after tax rose 42% to SEK 347m.
Higher volumes, improved project execution and efficiency supported profitability across all markets; a substantial data-centre pipeline and strong backlog underpin expected growth and gradual margin improvement.
Financial highlights
Q3 net sales were SEK 7,027m versus SEK 6,433m; organic growth was 9% versus -3%, while currency effects contributed 1%.
Q3 EBITA was SEK 460m versus SEK 342m; reported margin was 6.5%, or 6.7% adjusted for SEK 8m of non-recurring costs.
9M net sales increased 7% to SEK 21,701m; EBITA rose 32% to SEK 1,355m and profit after tax increased 37% to SEK 1,016m.
9M EBITA included a SEK 158m gain on the ABEKA divestment and SEK 68m of Swedish restructuring costs; adjusted EBITA margin was 5.8% versus 5.1%.
9M basic EPS was SEK 4.97 versus SEK 3.61; diluted EPS was SEK 4.96 versus SEK 3.61.
Outlook and guidance
Nordic markets are expected to grow gradually, with stronger demand in data centres, defence facilities, hospitals, transport infrastructure, electrification and digitalisation; housing new-build activity is expected to remain weak.
Record backlog with appropriate margin expectations, together with operating efficiency and balanced capacity, supports continued growth and gradual profitability improvement as projects convert to production.
Demand for small and medium projects and service remained strong overall, though new construction in Norway and parts of southern Sweden remained weaker or hesitant.
Latest events from Bravida
- Strong organic growth, record order intake, and margin expansion driven by data centre wins.BRAV
Q2 2026 - Net sales and EBITA rose, order backlog strengthened, and a SEK 100m share buyback was launched.BRAV
Q1 2026 - EBITA margin and EPS rose in Q4, with strong cash flow and a higher dividend proposed.BRAV
Q4 2025 - EBITA/EBITDA margin rose to 5.3% as Denmark outperformed, offsetting weak sales and markets.BRAV
Q3 2025 - EBITA margin rose to 5.4% and order intake increased 9% despite a 9% sales decline.BRAV
Q2 2025 - Flat sales, lower EBITA, and strong cash flow as service growth offsets market and restructuring headwinds.BRAV
Q3 2024 - Q2 sales up 5%, margin down to 4.5%, but cash flow and backlog strong; margin recovery expected.BRAV
Q2 2024 - EBITA margin rose to 4.5% as profit grew despite lower sales and market uncertainty.BRAV
Q1 2025 - Flat sales, improved margins, strong cash flow, and higher dividend despite market headwinds.BRAV
Q4 2024